The Role of Real-World Evidence in UK Reimbursement: Case Study of Lenalidomide in Myelodysplastic Syndrome Deletion 5q

Authors:

Lee D, Brereton N, Dhanasiri S, Kulasekararaj A

Publication type:

Journal article

Publication name:

PharmacoEconomics – Open

Citation:

Lee D, Brereton N, Dhanasiri S and Kulasekararaj A. The Role of Real-World Evidence in UK Reimbursement: Case Study of Lenalidomide in Myelodysplastic Syndrome Deletion 5q. PharmacoEconomics – Open. 2018:1-8.

Link to publication ⟶

⟵ Back to Search Results